Antonio Passaro: An honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs
Antonio Passaro, Medical Director with Highly Specialized Position at
“It’s an honor to have been a part of this significant manuscript, just out in Annals of Oncology driving forward the clinical development of ADCs, under the leadership of Peters Solange and Rolf Stahel, on behalf of ETOP IBCSG Partners Foundation.
Titled ‘Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation,’ this manuscript stands as a testament to our collective dedication and expertise in the field. By meticulously addressing pivotal research questions, we’re not only expanding the boundaries of knowledge but also laying the groundwork for enhanced clinical outcomes
Below you can find the full link of the article. Any commments are welcome, contributing to the progress and clinical research in this complex field, represented by breast and lung cancer.”
Source: Antonio Passaro/LinkedIn
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.